We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.
- Authors
Schwenkglenks, Matthias; Pettengell, Ruth; Jackisch, Christian; Paridaens, Robert; Constenla, Manuel; Bosly, André; Szucs, Thomas D; Leonard, Robert
- Abstract
Chemotherapy-induced neutropenia (CIN) places patients at risk of life-threatening infections. While reduction of chemotherapy dose or delay of the subsequent treatment cycle and, consequently, reduction of relative dose intensity (RDI) may limit myelotoxicity, these actions can also impact adversely on treatment outcome and should be avoided in adjuvant settings.
- Publication
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Vol 19, Issue 4, p483
- ISSN
1433-7339
- Publication type
Journal Article
- DOI
10.1007/s00520-010-0840-y